Regulatory overview:IVDR is the EU In Vitro Diagnostic Medical Devices Regulation, principally covering devices providing specified diagnostic information through in vitro examination of human-derived specimens. A general laboratory equipment designation or a single label cannot replace analysis of intended purpose and legal definitions.

Scope and boundaries

2017/746 covers qualifying reagents, kits, instruments, equipment, software and other devices. Boundaries between general laboratory products, research-use-only products and IVDs depend on manufacturer-specified intended purpose and statutory conditions.

Classification from A to D

Annex VIII establishes risk classification rules for classes A, B, C and D. Classification considers individual and public health risks and other factors; MDR classes I, IIa, IIb and III cannot simply be reused.

Principal obligations

The regulation connects quality management, risk management, technical documentation and performance evaluation, including scientific validity, analytical performance and clinical performance. Post-market performance follow-up, surveillance and vigilance are ongoing responsibilities, continuing beyond initial market documentation.

Supply chain roles and related rules

Manufacturers, authorised representatives, importers and distributors have their respective duties. MDR and IVDR cover different products. EUDAMED and UDI provide information and traceability systems and do not replace device safety and performance duties.

Application date and transitional conditions

IVDR has applied since 2022-05-26. Article 110 and amendments govern legacy device transitions, subject to class, certificates and other conditions. Amendments such as 2024/1860 are not a universal extension for all new products.

Official sources and applicability limits

The following are official EU legislation and implementation explanations. This article introduces general structure and applicability boundaries. Legal effect rests with Official Journal texts and amendments; Commission guidance provides supporting interpretation. Where official topic pages have no separate publication date, this review date is the access date.